Primary Site >> Liver Cancer
Gene >> LATS1
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: The need for new antiviral agents. PMID: 3004326 |
Ref: Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. PMID: 19762333 Ref: Mst out and HCC in. PMID: 19878866 Ref: Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. PMID: 19878874 |
Ref: YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor. PMID: 22632819 Ref: Function and cancer genomics of FAT family genes (review). PMID: 23076869 |
Ref: Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation. PMID: 25632982 |
Ref: The Hippo signaling pathway in liver regeneration and tumorigenesis. PMID: 25476204 Ref: Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells. PMID: 25625370 Ref: Emerging role of Hpo signaling and YAP in hepatocellular carcinoma. PMID: 27508196 |
Ref: Integrin alpha2beta1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma. PMID: 27765911 Ref: Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma. PMID: 27767105 |
Ref: Blocking inhibition to YAP by ActinomycinD enhances anti-tumor efficacy of Corosolic acid in treating liver cancer. PMID: 27836738 Ref: Transforming growth factor-beta1 suppresses hepatocellular carcinoma proliferation via activation of Hippo signaling. PMID: 28076850 Ref: TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma. PMID: 28152516 Ref: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway. PMID: 28273460 Ref: A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. PMID: 28420424 Ref: Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer. PMID: 28502290 Ref: WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma. PMID: 28815883 Ref: Promotion of LncRNA HOXA11-AS on the proliferation of hepatocellular carcinoma by regulating the expression of LATS1. PMID: 28829501 Ref: [Research advances in the role of the Hippo signaling pathway in pathogenesis of liver cancer]. PMID: 29108216 |
Ref: Clinical implications of the Hippo-YAP pathway in multiple cancer contexts. PMID: 29366445 Ref: Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and beta-catenin in gastric cancer. PMID: 29374493 Ref: SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways. PMID: 29440144 Ref: NEDD4 promotes cell growth and motility in hepatocellular carcinoma. PMID: 29480061 Ref: Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors. PMID: 29558384 Ref: Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma. PMID: 29901195 Ref: LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling. PMID: 30219064 Ref: Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway. PMID: 30251417 Ref: A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway. PMID: 30308519 |